Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Navel administration pill for treating hepatic ascites and preparation method thereof

A technology of belly button pills and liver ascites, which is applied in the field of belly button pills and its preparation for the treatment of liver ascites, and can solve the problems of renal blood flow, sodium excretion and urination reduction, ineffective diuresis, complex pathogenesis of ascites, etc.

Inactive Publication Date: 2018-04-27
吴春生
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

4. Increased renal sodium reabsorption due to secondary aldosteronism
6. Insufficient effective circulating blood volume: increased sympathetic nerve activity, decreased prostaglandin, atrium, and kallikrein-kinin activities, resulting in decreased renal blood flow, sodium excretion, and urine output
[0005] Due to the complex pathogenesis of ascites, different deficiency and excess, cold and heat, and changeable conditions, it is often difficult for traditional Chinese medicine to use fixed prescriptions to meet clinical needs.
Early Chinese medicine used fixed prescriptions, single herbs such as kansui, croton, genkwa, pokeweed, euphorbia, Erchou, etc.; because they mainly excrete water through the intestinal tract, but the diuresis is not obvious, and due to the violent reaction, it is easy to cause electrolyte disorder, so few people use this method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] A navel pill for treating hepatic ascites. The raw materials for preparing the navel pill include, in parts by weight, 20 parts of turmeric, 30 parts of gardenia, 20 parts of Qingdai, 30 parts of crocodile, 20 parts of purple ginseng, 30 parts of sand ginseng, 18 parts of rhubarb, 40 parts of licorice, 25 parts of poria cocos, 40 parts of Qingpi, 25 parts of Fangji, 40 parts of cardamom, 15 parts of blanc berry, 25 parts of clove, 1 part of asarum, and 100 parts of honey.

[0041] The preparation method of the navel pill for the treatment of hepatic ascites, comprises the steps:

[0042] Step (1): Weigh turmeric, gardenia, Qingdai, scrophulariaceae, purple ginseng, Radix ginseng, rhubarb, licorice, Poria cocos, green bark, Fangji, cardamom, wangbu Retainer, clove, and asarum; after being cleaned separately, put them in an oven for drying, the drying temperature is controlled at 50°C, and the moisture content of each drug is controlled at 5-9% after drying;

[0043] Ste...

Embodiment 2

[0048] A navel pill for treating hepatic ascites. The raw materials for preparing the navel pill include in parts by weight: 30 parts of curcuma, 20 parts of gardenia, 30 parts of Qingdai, 20 parts of crocodile, 30 parts of purple ginseng, 20 parts of sand ginseng, 25 parts of rhubarb, 25 parts of licorice, 40 parts of poria cocos, 25 parts of Qingpi, 40 parts of Fangji, 25 parts of cardamom, 30 parts of blanc berry, 10 parts of clove, 3 parts of asarum, and 100 parts of honey.

[0049] The preparation method of the navel pill for the treatment of hepatic ascites, comprises the steps:

[0050] Step (1): Weigh turmeric, gardenia, Qingdai, scrophulariaceae, purple ginseng, Radix ginseng, rhubarb, licorice, Poria cocos, green bark, Fangji, cardamom, wangbu Retainer, clove, and asarum; after being cleaned separately, put them in an oven for drying, the drying temperature is controlled at 50°C, and the moisture content of each drug is controlled at 5-9% after drying;

[0051] Step...

Embodiment 3

[0056] A navel pill for treating hepatic ascites. The raw materials for preparing the navel pill include in parts by weight: 28 parts of curcuma, 22 parts of gardenia, 28 parts of Qingdai, 23 parts of crocodile, 28 parts of purple ginseng, 21 parts of sand ginseng, 23 parts of rhubarb, 30 parts of licorice, 35 parts of poria cocos, 28 parts of Qingpi, 35 parts of Fangji, 28 parts of cardamom, 25 parts of blanc berry, 15 parts of clove, 3 parts of asarum, and 100 parts of honey.

[0057] The preparation method of the navel pill for the treatment of hepatic ascites, comprises the steps:

[0058] Step (1): Weigh turmeric, gardenia, Qingdai, scrophulariaceae, purple ginseng, Radix ginseng, rhubarb, licorice, Poria cocos, green bark, Fangji, cardamom, wangbu Retainer, clove, and asarum; after being cleaned separately, put them in an oven for drying, the drying temperature is controlled at 50°C, and the moisture content of each drug is controlled at 5-9% after drying;

[0059] Step...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to a navel administration pill for treating hepatic ascites and a preparation method thereof. Thenavel administration pill comprises, by weight, 20 to 30 parts of radix curcumae, 20 to 30 parts of cape jasmine, 20 to 30 parts of indigo naturalis, 20 to 30 parts of radix scrophulariae, 20 to 30 parts of Rubia yunnanensis Diels, 20 to 30 parts of root of straight ladybell, 18 to 25 parts of rheum officinale, 25 to 40 parts of licorice root, 25 to 40 parts of poria cocos, 20 to 30 parts of pericarpium citri reticulatae viride, 25 to 40 parts of Stephania tetrandra, 25 to 40 parts of katsumade galangal seed, 15 to 30 parts of seed of cowherb, 10 to 25 parts of clove, 1 to 3 parts of herba asari and 100 parts of honey. The navel administration pill can directly acts on lesions through navel administration without using absorption in the gastrointestinal tract, does not damage the liver, has good therapeutic effects on the large and small intestines in the viscera area, can promote small intestinal absorption and colon excretion, can realize liver disease treatment and intestinal disease treatment, can produce good effects fast and is suitable for long-term use of patients with liver ascites symptoms.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a navel pill for treating liver ascites and a preparation method thereof. Background technique [0002] Cirrhotic ascites is commonly known as liver ascites. There is a small amount of free ascites in the abdominal cavity of normal people, generally about 50 ml, which plays a role in maintaining lubrication between organs. When there is too much free fluid in the abdominal cavity, it is called ascites. Cirrhotic ascites is a chronic liver disease. Massive, nodular, and diffuse hepatocyte degeneration, necrosis, and regeneration; regeneration, necrosis, and tissue fibrous hyperplasia and scar shrinkage, resulting in hardening of the liver and the formation of cirrhosis. Cirrhotic liver dysfunction causes portal hypertension, leading to splenomegaly, and the leakage of protein fluid due to non-absorption of protein and vitamins, forming ascites. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61K9/20A61P1/16A61K35/644
CPCA61K9/20A61K35/644A61K36/076A61K36/195A61K36/23A61K36/268A61K36/315A61K36/34A61K36/342A61K36/36A61K36/484A61K36/53A61K36/59A61K36/61A61K36/704A61K36/708A61K36/74A61K36/744A61K36/752A61K36/808A61K36/81A61K36/9062A61K36/9066A61K2300/00
Inventor 吴春生吴哲吴晓旭吴玉红王萌
Owner 吴春生
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products